FDA UDI
In Commercial Distribution
🇺🇸 United States
Rapid Response
DI: 10722066006624
·
Model: D10.3.2-2FC1E
·
BTNX Inc
Product Codes
13
GMDN Terms
1
Identifiers
2
Pkg Device Count
25
Basic Information
- Brand Name
- Rapid Response
- Primary DI
- 10722066006624
- Version / Model
- D10.3.2-2FC1E
- Company Name
- BTNX Inc
- Labeler DUNS
- 251005005
- Distribution Status
- In Commercial Distribution
- Device Count in Pkg
- 25
- Record Status
- Published
- Publish Date
- 2022-12-07
- Public Version
- 2
- Public Version Date
- 2023-04-20
- Public Version Status
- Update
- Public Device Record Key
- db5042e6-7906-40aa-88b6-69d8b485c1d5
Device Description
Rapid Response 10 Panel Saliva Test Cup E/I Screening (D10.3.2-2FC1E)- THC40, COC20, OPI40, AMP50, MET50, BAR50, BZO10, MDMA50, MTD30, PPX50. For employment and insurance testing.
Device Characteristics
- Single Use
- Yes
- Prescription Use (Rx)
- No
- Over the Counter (OTC)
- No
- Kit
- Yes
- Combination Product
- No
- HCT/P
- No
- Contains NRL
- No
- Not Made with NRL
- No
- MRI Safety
- Labeling does not contain MRI Safety Information
- Direct Marking Exempt
- No
- PM Exempt
- No
- Has Serial Number
- No
- Has Lot/Batch Number
- Yes
- Has Manufacturing Date
- No
- Has Expiration Date
- Yes
- Has Donation ID
- No
Sterilization
- Is Sterile
- No
- Sterilization Prior Use
- No
Product Codes
| Code | Name | Medical Specialty | Regulation # | Device Class |
|---|---|---|---|---|
| PVI | Test, Propoxyphene, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3700 | 2 |
| PUX | Test, Amphetamine, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3100 | 2 |
| PUY | Test, Barbiturate, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3150 | 2 |
| PUZ | Test, Benzodiazepine, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3170 | 2 |
| PVA | Test, Cocaine And Cocaine Metabolite, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3250 | 2 |
| PVB | Test, Codeine, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3270 | 2 |
| PVD | Test, Methamphetamine, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3610 | 2 |
| PVE | Test, Methadone, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3620 | 2 |
| PVF | Test, Methaqualone, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3630 | 2 |
| PVK | Test, Tricyclic Antidepressant Drugs, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3910 | 2 |
| PVJ | Test, Cannabinoid, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3870 | 2 |
| PVG | Test, Morphine, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3640 | 2 |
| PVH | Test, Opiates, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3650 | 2 |
GMDN Terms
| Code | Name | Definition | Implantable | Status |
|---|---|---|---|---|
| 46994 | Multiple drugs of abuse IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of multiple drugs of abuse in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
Identifiers
| Type | ID | Issuing Agency | Package Type | Qty per Pkg | Pkg Status | Pkg Discontinue Date |
|---|---|---|---|---|---|---|
| Unit of Use | 00722066006627 | GS1 | ||||
| Primary | 10722066006624 | GS1 |